State Street’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $642M | Buy |
18,936,548
+1,146,528
| +6% | +$38.2M | 0.02% | 521 |
|
|
2026
Q1 | $536M | Buy |
17,790,020
+441,211
| +3% | +$14.2M | 0.02% | 536 |
|
|
2025
Q4 | $541M | Buy |
17,348,809
+198,558
| +1% | +$4.89M | 0.02% | 544 |
|
|
2025
Q3 | $346M | Sell |
17,150,251
-136,762
| -0.8% | -$2.4M | 0.01% | 679 |
|
|
2025
Q2 | $290M | Sell |
17,287,013
-34,312
| -0.2% | -$554K | 0.01% | 719 |
|
|
2025
Q1 | $266M | Sell |
17,321,325
-2,092,722
| -11% | -$37.4M | 0.01% | 735 |
|
|
2024
Q4 | $428M | Sell |
19,414,047
-86,636
| -0.4% | -$1.58M | 0.02% | 578 |
|
|
2024
Q3 | $351M | Buy |
19,500,683
+1,778,268
| +10% | +$31.1M | 0.01% | 646 |
|
|
2024
Q2 | $288M | Buy |
17,722,415
+1,499,143
| +9% | +$23.1M | 0.01% | 679 |
|
|
2024
Q1 | $229M | Sell |
16,223,272
-142,754
| -0.9% | -$1.8M | 0.01% | 806 |
|
|
2023
Q4 | $171M | Buy |
16,366,026
+360,683
| +2% | +$3.37M | 0.01% | 940 |
|
|
2023
Q3 | $163M | Buy |
16,005,343
+431,999
| +3% | +$4.02M | 0.01% | 879 |
|
|
2023
Q2 | $117M | Sell |
15,573,344
-3,991,484
| -20% | -$32.4M | 0.01% | 1108 |
|
|
2023
Q1 | $173M | Buy |
19,564,828
+4,441,883
| +29% | +$43.9M | 0.01% | 848 |
|
|
2022
Q4 | $138M | Buy |
15,122,945
+221,012
| +1% | +$1.93M | 0.01% | 960 |
|
|
2022
Q3 | $120M | Buy |
14,901,933
+1,055,920
| +8% | +$9.34M | 0.01% | 1002 |
|
|
2022
Q2 | $104M | Sell |
13,846,013
-1,744,479
| -11% | -$15.2M | 0.01% | 1123 |
|
|
2022
Q1 | $146M | Sell |
15,590,492
-1,882,500
| -11% | -$15.7M | 0.01% | 1043 |
|
|
2021
Q4 | $140M | Sell |
17,472,992
-60,575
| -0.3% | -$547K | 0.01% | 1046 |
|
|
2021
Q3 | $171M | Buy |
17,533,567
+1,130,428
| +7% | +$10.6M | 0.01% | 924 |
|
|
2021
Q2 | $162M | Sell |
16,403,139
-154,144
| -0.9% | -$1.63M | 0.01% | 966 |
|
|
2021
Q1 | $191M | Sell |
16,557,283
-171,602
| -1% | -$1.97M | 0.01% | 821 |
|
|
2020
Q4 | $161M | Buy |
16,728,885
+246,762
| +1% | +$2.36M | 0.01% | 838 |
|
|
2020
Q3 | $149M | Buy |
16,482,123
+817,268
| +5% | +$8.65M | 0.01% | 788 |
|
|
2020
Q2 | $193M | Buy |
15,664,855
+261,870
| +2% | +$2.96M | 0.01% | 668 |
|
|
2020
Q1 | $138M | Buy |
15,402,985
+2,863,465
| +23% | +$29.3M | 0.01% | 722 |
|
|
2019
Q4 | $123M | Buy |
12,539,520
+638,141
| +5% | +$5.7M | 0.01% | 916 |
|
|
2019
Q3 | $81.9M | Sell |
11,901,379
-681,800
| -5% | -$5.22M | 0.01% | 1125 |
|
|
2019
Q2 | $116M | Buy |
12,583,179
+1,960,758
| +18% | +$23.6M | 0.01% | 935 |
|
|
2019
Q1 | $167M | Buy |
10,622,421
+886,511
| +9% | +$15.6M | 0.01% | 738 |
|
|
2018
Q4 | $150M | Buy |
9,735,910
+175,784
| +2% | +$3.6M | 0.01% | 710 |
|
|
2018
Q3 | $206M | Buy |
9,560,126
+1,545,420
| +19% | +$35.9M | 0.02% | 700 |
|
|
2018
Q2 | $195M | Buy |
8,014,706
+418,408
| +6% | +$8.53M | 0.02% | 700 |
|
|
2018
Q1 | $130M | Sell |
7,596,298
-1,282,545
| -14% | -$25M | 0.01% | 857 |
|
|
2017
Q4 | $168M | Buy |
8,878,843
+1,851,036
| +26% | +$27.8M | 0.01% | 753 |
|
|
2017
Q3 | $124M | Buy |
7,027,807
+2,264,115
| +48% | +$50.9M | 0.01% | 867 |
|
|
2017
Q2 | $158M | Buy |
4,763,692
+232,924
| +5% | +$7.21M | 0.01% | 737 |
|
|
2017
Q1 | $145M | Buy |
4,530,768
+621,795
| +16% | +$21.2M | 0.01% | 771 |
|
|
2016
Q4 | $142M | Buy |
3,908,973
+3,231,791
| +477% | +$129M | 0.01% | 743 |
|
|
2016
Q3 | $31.2M | Buy |
677,182
+55,006
| +9% | +$2.87M | ﹤0.01% | 1481 |
|
|
2016
Q2 | $31.3M | Sell |
622,176
-127,438
| -17% | -$6.78M | ﹤0.01% | 1434 |
|
|
2016
Q1 | $40.1M | Sell |
749,614
-169,848
| -18% | -$9.97M | ﹤0.01% | 1263 |
|
|
2015
Q4 | $60.4M | Buy |
919,462
+155,135
| +20% | +$9.59M | 0.01% | 1074 |
|
|
2015
Q3 | $43.2M | Sell |
764,327
-248,634
| -25% | -$16.1M | 0.01% | 1258 |
|
|
2015
Q2 | $60M | Sell |
1,012,961
-85,210
| -8% | -$5.26M | 0.01% | 1154 |
|
|
2015
Q1 | $68.4M | Buy |
1,098,171
+43,024
| +4% | +$2.5M | 0.01% | 1065 |
|
|
2014
Q4 | $60.7M | Sell |
1,055,147
-140,752
| -12% | -$7.84M | 0.01% | 1122 |
|
|
2014
Q3 | $64.3M | Buy |
1,195,899
+20,300
| +2% | +$1.08M | 0.01% | 1044 |
|
|
2014
Q2 | $61.6M | Sell |
1,175,599
-1,606
| -0.1% | -$82.1K | 0.01% | 1119 |
|
|
2014
Q1 | $62.2M | Sell |
1,177,205
-16,351
| -1% | -$756K | 0.01% | 1083 |
|
|
2013
Q4 | $47.8M | Buy |
1,193,556
+166,129
| +16% | +$6.54M | 0.01% | 1217 |
|
|
2013
Q3 | $38.8M | Buy |
1,027,427
+220,176
| +27% | +$8.59M | ﹤0.01% | 1301 |
|
|
2013
Q2 | $31.6M | Buy |
+807,251
| New | +$31.4M | ﹤0.01% | 1351 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
State Street's TEVA Position: Q2 2026 in Review
State Street increased its Teva Pharmaceuticals (TEVA) stake by 6.4% in Q2 2026, buying an estimated $38.2M and bringing the position to 18,936,548 shares worth $642M. The position accounts for 0.02% of the portfolio, ranked #521.
State Street first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- State Street held 18,936,548 shares of Teva Pharmaceuticals worth $642M as of Q2 2026.
- State Street bought 1,146,528 Teva Pharmaceuticals shares in Q2 2026, an estimated $38.2M.
- Teva Pharmaceuticals made up 0.02% of State Street's portfolio in Q2 2026, its #521 holding.
- State Street first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.